Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.
about
Isolation and functional expression of human COQ3, a gene encoding a methyltransferase required for ubiquinone biosynthesisCoenzyme Q10 for Parkinson's diseaseCoenzyme Q10 for Parkinson's diseaseInhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesNutraceuticals in Parkinson's DiseaseAnti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewBeneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in ratsMitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingNeuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's diseaseMitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Decylubiquinone increases mitochondrial function in synaptosomesTargeting cellular energy production in neurological disorders.Review: management of Parkinson's disease.Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.Antioxidants as treatment for neurodegenerative disorders.The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeuticsThe role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.Mitochondrial nutrition as a strategy for neuroprotection in Parkinson's disease—research focus in the department of alternative medicine and experimental therapeutics at Hokuriku UniversityPhysiological phenotype and vulnerability in Parkinson's diseaseReducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease.Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.Redox signaling pathways involved in neuronal ischemic preconditioningGenetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Calcium homeostasis, selective vulnerability and Parkinson's diseaseNanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's DiseaseTargeting the progression of Parkinson's disease.Targets for neuroprotection in Parkinson's diseaseMitochondrial biology and oxidative stress in Parkinson disease pathogenesis.Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.Mitochondrial approaches for neuroprotectionCoenzyme Q10 effects in neurodegenerative disease.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.
P2860
Q22253956-9FA12FE9-89F9-4FF6-B5BD-3181DC8A1080Q24198033-34F7C120-2FC2-4EE4-BE43-6E6860A8E002Q24234491-F61DE0D5-1E8B-490E-960D-B69944738F97Q24609725-F96FF46C-175E-4C14-A20E-F58D062FCE74Q26747508-4B8050F5-A1AF-4E4A-819E-2652FE43D363Q26752769-DC7B2D54-379A-48BD-823B-05A8918AAE86Q28084254-2A2A6AFD-26C0-4DBA-B1E2-7B5775406848Q28473890-8C9F5815-802C-4545-8545-A1902FF2D674Q28732683-AF3F502D-D1E5-4823-86C5-AB914FD2A657Q33499111-97403EE5-26F5-474D-9625-AD1A5780FF54Q33644322-5463991F-3184-443B-AAA4-2ADD02787C8AQ33726402-7799CA13-CCF4-4D91-93AE-1103891D8B1CQ34266266-0948DB8F-A88B-4E3C-A5EC-154B556E237AQ34332812-5FDBC7F4-4138-4B04-972B-7464D34E4E60Q34460675-61254D84-6F83-4CEA-B6D8-ACDC36D9F464Q34584417-71A155EC-F52D-4012-9447-DE2D89E9FF77Q34711201-EC7919DE-A6E0-4FBF-9E0F-CCA1253DDE2DQ34974866-B8B53A59-DDB5-41C6-A475-1985334B9778Q35216140-0E34E098-26AC-4481-A835-22AC7A5ABEB0Q35628604-7183EA18-409A-4930-8D1A-9002AFF44FF9Q35756089-137B7BF8-E8A4-41D6-BBD2-B5BE6D60E5CAQ35809081-7242D340-1EDE-4130-996F-361331EFF656Q36065850-E126B3D3-F214-45D5-8A5B-BB2A8D3AC0B1Q36212135-50DDCCD9-0BA1-4ACB-B8EE-EC268925CAF5Q36225925-C7E69C2E-E042-43EE-B0AB-8DCC96EE71B0Q36369850-B5000ED1-10B8-4414-A378-247325459987Q36460627-A064B905-6192-405E-9767-4CDFE0EDB489Q36499640-EB5D30D4-1762-434C-8518-29E5010A2947Q36798264-DC4D70C1-793E-47D5-8169-A4FF63F52C2DQ36968109-2789BEC9-C041-47C3-ABF0-1E524FAE0836Q37211800-5C64ACED-1823-4D68-9FFA-0BDAB893DD13Q37299619-0EB1D2AD-3D6B-4B72-BB59-A713A78B0DB7Q37302453-6B2B020C-9B6F-4CB0-B708-B66AABC9E12DQ37315448-F1B17E4D-821A-4298-A1FB-97D07A81334BQ37334961-1DB28908-7317-4FE2-9A88-1C25CDC02362Q37348548-0FB4EC40-4C6C-4CD9-86AB-2C4BD86C5D0DQ37348590-DA481C1C-2B2D-4008-8827-07F428705216Q37448888-1B6874FD-B9DC-43AC-A5F8-C3EBBAD22FC0Q37580731-BABD23D4-BFCB-4BBC-987E-E34790162522Q37653023-E13B64C0-A4EA-4689-94C2-7581D0AA32D1
P2860
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@en
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@nl
type
label
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@en
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@nl
prefLabel
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@en
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@nl
P2093
P921
P1433
P1476
Coenzyme Q10 attenuates the 1- ...... paminergic axons in aged mice.
@en
P2093
P304
P356
10.1016/S0006-8993(97)01192-X
P407
P577
1998-02-01T00:00:00Z